Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the efficacy and safety of Ba679BR powder inhalation during the
continuous once/day administration to the patients with COPD using oxitropium bromide
(Tersigan® aerosol) as the comparator drug.